Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids

Lange's handbook of chemistry

Lange, N. A., & Speight, J. G. (1992) · Choice Reviews Online · doi:10.5860/choice.30-1849 · Cited by 7,163

STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES

Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,438

Structure of 20S proteasome from yeast at 2.4Å resolution

Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,265

Crystal Structure of the 20 S Proteasome from the Archaeon T. acidophilum at 3.4 Å Resolution

Löwe, J., Stock, D., Jap, B. K., Zwickl, P., Baumeister, W. P., & Huber, R. (1995) · Science · doi:10.1126/science.7725097 · Cited by 1,540

Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids.

Kettner, C. A., & Shenvi, A. B. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42521-x · Cited by 294

The selective inhibition of thrombin by peptides of boroarginine.

Kettner, C. A., Mersinger, L. J., & Knabb, R. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44751-x · Cited by 254

Inhibition of serine proteases by peptidyl fluoromethyl ketones

Imperiali, B., & Abeles, R. H. (1986) · Biochemistry · doi:10.1021/bi00361a005 · Cited by 248

R-1-Acetamido-2-phenylethaneboronic acid. A specific transition-state analog for chymotrypsin

Matteson, D. S., Sadhu, K. M., & Lienhard, G. E. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00407a051 · Cited by 153

Design, synthesis, and kinetic evaluation of a unique class of elastase inhibitors, the peptidyl .alpha.-ketobenzoxazoles, and the x-ray crystal structure of the covalent complex between porcine pancreatic elastase and Ac-Ala-Pro-Val-2-benzoxazole

Edwards, P. D., Meyer, E. F., Vijayalakshmi, J., Tuthill, P. A., Andisik, D., Gomes, B. C., & Strimpler, A. M. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00031a046 · Cited by 145

Kinetic Characterization of the Chymotryptic Activity of the 20S Proteasome

Stein, R. L., Melandri, F. D., & Dick, L. R. (1996) · Biochemistry · doi:10.1021/bi952262x · Cited by 138

Advances in Organoboron Chemistry

Roland, S., & Norsikian, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-32-390644-9.00110-4 · Cited by 1

Protein Oxidation in Some Age‐Related Diseases

Grune, T., Karademir-Yilmaz, B., & Jung, T. (2012) · Wiley eBooks · doi:10.1002/9781118493038.ch4 · Cited by 1

Removal of Oxidized Proteins

Grune, T., Karademir-Yilmaz, B., & Jung, T. (2012) · Wiley eBooks · doi:10.1002/9781118493038.ch2 · Cited by 1

Antineoplastic Agents, 1. Nonhormonal

Kleemann, A. (2010) · Ullmann's Encyclopedia of Industrial Chemistry · doi:10.1002/14356007.a05_001.pub2 · Cited by 1

Caracterização de putativo receptor serpentino e estudos sobre a implicação do sistema de ubiquitina/proteossomo na modulação do ciclo celular de Plasmodium falciparum.

Koyama, F. C. (2012) · doi:10.11606/t.42.2012.tde-20092012-093053 · Cited by 1

From orbital hybridization to chemotherapeutics neutralization

Ghosh, N., & Emadi, A. (2009) · Blood · doi:10.1182/blood-2009-03-209148 · Cited by 1

Diaphragm dysfunction in heart failure from myofilaments to pharmacological targets.

van Hees, H. W. H. (2009) · Radboud Repository (Radboud University) · Cited by 1

Organische Chemie 2004

Würthner, F., & Tschierske, C. (2005) · Nachrichten aus der Chemie · doi:10.1002/nadc.20050530311 · Cited by 1

Proteasome Inhibitors: Recent Progress and Future Directions

Wehenkel, M., Ho, Y. K., & Kim, K. (2009) · Cited by 1

Purification and characterisation of 20S proteasome from ostrich skeletal muscle and its role in meat tenderisation

Thomas, A. R. (2004) · Nelson Mandela University Research Repository · Cited by 1

Image-based phenotypic profiling of a chemogenomic screening library identifies novel druggable targets in the EGFR-pathwayPreprint

Tanabe, K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.16.440090 · Cited by 1

SM Journal of Nephrology and Therapeutics

(2019) · SM Journal of Nephrology and Therapeutics · doi:10.36876/smjnt · Cited by 1

Cancer – Proteases in Progression and Metastasis

Ji, K., & Sloane, B. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00236-4 · Cited by 2

Regulation of NFATc3 stability by SUMO and E3 ubiquitin-ligases Trim39 and Trim17

Basu-Shrivastava, M. (2020) · theses.fr (ABES) · doi:10.70675/0aa33054zc607z413dz8aedz05ed052d5438 · Cited by 1

A NOVEL CLASS OF IMMUNOPROTEASOME CATALYTIC SUBUNIT LMP2 INHIBITOR AND ITS THERAPEUTIC POTENTIALS IN CANCER

Ho, Y. K. (2008) · UKnowledge (University of Kentucky) · Cited by 1

Proteasom-Inhibition überwindet die Resistenz von Nierenzellkarzinom-Zelllinien gegenüber PPARgamma-Aktivierung

von Schwarzenberg, K. (2009)

Bortezomib with Taxanes

Liebes, L., Ng, B., Ling, Y.-H., & Perez-Soler, R. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-794-9_12

Design of Proteasome Inhibitors

Ghosh, A. K., & Gemma, S. (2014) · Wiley eBooks · doi:10.1002/9783527665211.ch4

Proteasome Targeted Therapies in Rheumatoid Arthritis

Ahmed, A. S. (2012) · InTech eBooks · doi:10.5772/25624

Activity‐Based Proteasome Profiling in Medicinal Chemistry and Chemical Biology

de Bruin, G., Li, N., Paniagua, G., Willems, L. I., Xin, B., Verdoes, M., Geurink, P. P., van der Linden, W. A., van der Stelt, M., MAREL, G. V. D., et al. (2014) · Wiley eBooks · doi:10.1002/9783527687503.ch12

Structures of the Yeast Proteasome Core Particle in Complex with Inhibitors

Groll, M., & Huber, R. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-794-9_3

Studies on the biosynthesis and isolation of the biosynthetic gene cluster for the salinosporamides of the marine bacterium Salinispora tropica

Beer, L. L. (2006)

Asymmetric Homologation of Boronic Esters with Lithiated Carbamates, Epoxides, and Aziridines

Webster, M. P., & Aggarwal, V. K. (2011) · Wiley eBooks · doi:10.1002/9783527639328.ch10

Novel Therapeutic Targets in ALL Therapy

Crazzolara, R. (2011) · InTech eBooks · doi:10.5772/25998

X-ray structure analysis of a pathogenic bacterial protease from Stenotrophomonas maltophilia towards drug discovery

Negm, A. (2011)

Target validation of UK-101 and functional studies of beta1i

Wehenkel, M. (2011)

Der Einfluss des Proteasominhibitors Bortezomib auf die kardiale Hypertrophie in der Dahl Salz-sensitiven Ratte

Fechner, M. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4638

Genexpression der katalytischen Untereinheiten des Proteasoms in unterschiedlichen Zellpopulationen des Immunsystems beim Sjögren-Syndrom

Lesemann, K. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-18034

Regulation of polyamine biosynthesis in Saccharomyces cerevisiae

Murugan, R. P. (2005) · Kölner Universitäts PublikationsServer (Universität zu Köln)

Characterization of malignant pleural mesothelioma : possibilities for an individualized therapeutic arsenal

Szulkin, A. (2014) · Figshare

A Quantitative Method to Monitor the Efficacy of Inhibitors Against the Chymotrypsin-Like Activity of the Proteasome in Tobacco Leaf Protoplasts

Cascio, P., Cerruti, F., Marshall, R. S., Raule, M., Remelli, W., Roberts, L. M., & Ceriotti, A. (2014) · Plant Molecular Biology Reporter · doi:10.1007/s11105-014-0793-2

Bortezomib: clinical profile in lymphoproliferative malignancies

O’Connor, O. A. (2004) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2004.04.005

Amine-Catalyzed B−O−C Bond Formation: Mechanistic Insights from Density Functional Theory and Second-Order Møller−Plesset Perturbation Theory

Bhat, K. L., Lai, J. H.-S., Markham, G. D., DiJulio, A. M., & Bock, C. W. (2006) · Organometallics · doi:10.1021/om0509239

Plasticity of nervous and immune systems in different species: The role of proteasomes

Lyupina, Y. V., Orlova, A. S., Gornostayev, N. G., Karpova, Y. D., Mikhailov, V. S., & Sharova, N. P. (2014) · Biology Bulletin Reviews · doi:10.1134/s2079086414050041

Ctla-4 transcriptional activation: regulation of induced expression

Gibson, H. M. (2011) · Human Biology

Strategies for reducing damage while optimizing therapeutic dosage

Wiebe, E. M., & Rodrigues, G. (2006)

Cancer – Proteases in the Progression and Metastasis

Ji, K., & Sloane, B. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.10085-9

TOWARDS DEVELOPING SPECIFIC INHIBITORS OF THE ATP-DEPENDENT LON PROTEASE

Frase, H. (2007) · OhioLink ETD Center (Ohio Library and Information Network)

Diabetic Retinopathy, Inflammation, and Proteasome

Ambrósio, A. F., Pereira, P., & Cunha-Vaz, J. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_22

Multilayered thin films from poly(amido amine)s for controlled delivery

Hujaya, S. D. (2014) · doi:10.3990/1.9789036537704

Charakterisierung der proteasomalen Genregulation unter Biogeneseaspekten

Mathematisch-naturwissenschaftlichen Fakultät, I. (2005)

Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München

Gründler, K. (2015)

Proteasom‐Inhibitoren

Steverding, D. (2012) · Chemie in unserer Zeit · doi:10.1002/ciuz.201200569

TOWARDS DEVELOPING SPECIFIC INHIBITORS OF THE ATP-DEPENDENT

Protease, L., & Frase, H. (2007)

[Classification and synthesis of ubiquitin-proteasome inhibitor].

Li, J., Zhang, D.-Y., & Wu, X. (2009) · PubMed

Structure-based design and synthesis of bimodal proteasome inhibitors as therapeutic agents

Strater, Z. M. (2014)

in vivo synergistic cytotoxicity in multiple myeloma Combination of proteasome inhibitors bortezomib and NPI-0052 trigger

Munshi, N. C., Palladino, M. A., Anderson, K. C., Chauhan, D., Singh, A., Brahmandam, M., Podar, K., & Hideshima, T. (2008)

animal model for COPD Proteasome inhibition improves diaphragm function in an

Heunks, L. M. A., van Hees, H. W. H., Ottenheijm, C. A. C., Ennen, L., & Linkels, M. (2016)

Heterochromatin effects in Friedreich's ataxia and sexual dimorphism

Yandım, C. (2012) · Spiral (Imperial College London) · doi:10.25560/9644

Enzyme Inhibitors

Lednicer, D. (2015) · Wiley eBooks · doi:10.1002/9781118892572.ch9

Antineoplastic and Immunomodulating Agents (L)

Kleemann, A. (2017) · Ullmann's Encyclopedia of Industrial Chemistry · doi:10.1002/14356007.a05_001.pub3

The Development of Novel Non-Peptide Proteasome Inhibitors for the Treatment of Solid Tumors

Miller, Z. C. (2018) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2018.177

International Publication Trends in Proteasome Inhibitors: From Tools for Cell Biologists to Anticancer Agents

Zhou, P., Zhu, M., Zhang, C., Chen, D., & Zheng, H. (2019) · Letters in Drug Design & Discovery · doi:10.2174/1570180816666190325165106

Therapy of Multiple Myeloma and Myeloma-Related Kidney Disease

Fuchs, O. (2017) · SM Journal of Nephrology and Therapeutics · doi:10.36876/smjnt.1009

Rationale for Combining the Proteasome Inhibitor Bortezomib with Cisplatin

Mimnaugh, E. G., & Neckers, L. Μ. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-794-9_16

Modulating the Reactivity of Electrophilic Warheads for Pharmacokinetic Efficacy

Bogatchenko, M. (2018) · TSpace (University of Toronto)

Elucidating a Common Mechanism of Proteasome Impairment in Neurodegenerative Disease and its Pharmacological Intervention

Thibaudeau, T. A. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.3780

Enzymes as Drug Targets

Meek, T. D. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc260

Volumetric and Acoustic Properties of Phenylboronic Acid in Water at Selected Temperatures

Kul, I., Bhat, K. L., Knox, A., & Fischer-Drowos, S. G. (2021) · Journal of Solution Chemistry · doi:10.1007/s10953-021-01106-2

6 Borylation of Carbonyl and Imine Groups

Clark, T. B., & Cho, H. Y. (2019) · Haug Verlag in Georg Thieme Verlag KG eBooks · doi:10.1055/sos-sd-230-00065

Dégradation du canal KCNQ1 dans le syndrome du QT long : nouveaux partenaires des canaux KCNQ1 et SCN5A

Péroz, D. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)

Molecular Machines for Protein Degradation

Bochtler, M., Groll, M., Brandstetter, H., Clausen, T., & Huber, R. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch10

Antineoplastic and Immunomodulating Agents (L)

Kleemann, A. (2022) · Ullmann's Encyclopedia of Industrial Chemistry · doi:10.1002/14356007.a05_001.pub4

Structural Characterization of Proteasome Inhibition

Schrader, J. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6438

Proteasome Inhibitors

Wehenkel, M., & Kim, K. B. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc210

Proteasome Inhibition: Thinking outside the Box

Armstrong, M. B. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s3072

Data from Proteasome Inhibition Up-regulates p53 and Apoptosis-Inducing Factor in Chondrocytes Causing Severe Growth Retardation in Mice

Zaman, F., Menéndez-Benito, V., Eriksson, E., Chagin, A. S., Takigawa, M., Fadeel, B., Dantuma, N. P., Chrysis, D., & Savendahl, L. S. (2023) · doi:10.1158/0008-5472.c.6496529

Data from Proteasome Inhibition Up-regulates p53 and Apoptosis-Inducing Factor in Chondrocytes Causing Severe Growth Retardation in Mice

Zaman, F., Menéndez-Benito, V., Eriksson, E., Chagin, A. S., Takigawa, M., Fadeel, B., Dantuma, N. P., Chrysis, D., & Savendahl, L. S. (2023) · doi:10.1158/0008-5472.c.6496529.v1

General Introduction

Ozawa, Y. (2023) · Springer theses · doi:10.1007/978-981-99-1098-4_1

Probing the Molecular Function of Novel Boron-containing Compounds

Okura, G. C. (2024) · doi:10.32920/26052778.v1

The Role of Bortezomib in the Treatment of Relapsed and Refractory Multiple Myeloma

Richardson, P. G. G., Mitsiades, C. S., Schlossman, R. L., Hideshima, T., Ghobrial, I. M., Munshi, N. C., & Anderson, K. C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-564-0_15

Approches synthétiques vers la pactamycine et les raputindoles. Hétérocycles azotés par réaction multicomposant

Alves, R. R. (2018) · doi:10.70675/109a1dd9za184z49cfzb223z8fe627fa3fd7

Elucidating the interplay between the regulatory mechanisms of proteasome complexes with structural mass spectrometry

Dafun, A. S. (2024) · theses.fr (ABES) · doi:10.70675/d1d1515fz2674z4e7dz9fbezbf954bb71129

Resolving symmetry-masked allosteric cooperativity in the M. tuberculosis proteasome core particlePreprint

Turner, M., Wittlinger, V., Lento, C., Haris, A., Ujma, J., Bruton, D., Richardson, K., Giles, K., Böttcher, T., Wilson, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.02.736129

Stereochemical Control in the Matteson Reaction

Lee, H. M., & Hirschhäuser, C. (2026) · Chemistry - A European Journal · doi:10.1002/chem.71365

5- t Bu-Thalidomide Is a Selective Molecular Glue Degrader of the Transcription Factor FLT3 Interacting Zinc Finger 1 (FIZ1)

Brennan, P. J., Guo, R., Ordureau, A., Singleton, S. E., Li, M., Halaç, F. A., Chang, C. H., Yu-Liao, L., Deane, C. M., Houk, K. N., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c14185

BindingDB Entry 50042785: Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of action.

BindingDB (2013) · UC San Diego · doi:10.7270/q25m673w

BindingDB Entry 50032218: New approaches to molecular cancer therapeutics.

BindingDB (2011) · UC San Diego · doi:10.7270/q23t9hf8

BindingDB Entry 50010223: Structure-Based Design of β5c Selective Inhibitors of Human Constitutive Proteasomes.

BindingDB (2021) · UC San Diego · doi:10.7270/q2z60sj2

BindingDB Entry 50006705: Bis-benzoxaboroles: Design, Synthesis, and Biological Evaluation as Carbonic Anhydrase Inhibitors.

BindingDB (2021) · UC San Diego · doi:10.7270/q21c2137

BindingDB Entry 50031121: Incorporation of fluorinated phenylalanine generates highly specific inhibitor of proteasome's chymotrypsin-like sites.

BindingDB (2010) · UC San Diego · doi:10.7270/q2ws8tch

BindingDB Entry 50007950: Novel Cell-Penetrating Peptide Conjugated Proteasome Inhibitors: Anticancer and Antifungal Investigations.

BindingDB (2021) · UC San Diego · doi:10.7270/q2xg9vgv

BindingDB Entry 50046209: Structure-based design ofß1i orß5i specific inhibitors of human immunoproteasomes.

BindingDB (2016) · UC San Diego · doi:10.7270/q2br8tzt

BindingDB Entry 50003707: Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.

BindingDB (2020) · UC San Diego · doi:10.7270/q2cf9svn

BindingDB Entry 50013199: A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities.

BindingDB (2022) · UC San Diego · doi:10.7270/q2fn19xd

BindingDB Entry 50028612: Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047).

BindingDB (2010) · UC San Diego · doi:10.7270/q2zw1ks0

BindingDB Entry 50038136: Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.

BindingDB (2012) · UC San Diego · doi:10.7270/q2xg9s0r

BindingDB Entry 50032473: Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.

BindingDB (2011) · UC San Diego · doi:10.7270/q29c6xpm

BindingDB Entry 50009548: Boronate, trifluoroborate, sulfone, sulfinate and sulfonate congeners of oseltamivir carboxylic acid: Synthesis and anti-influenza activity.

BindingDB (2021) · UC San Diego · doi:10.7270/q2xg9vmn

BindingDB Entry 50028737: Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors.

BindingDB (2010) · UC San Diego · doi:10.7270/q2hh6jzw

BindingDB Entry 50034562: Design and synthesis of boronic acid inhibitors of endothelial lipase.

BindingDB (2012) · UC San Diego · doi:10.7270/q28g8m5n

BindingDB Entry 50013990: Structure-Based Design of Selective LONP1 Inhibitors for Probing

BindingDB (2022) · UC San Diego · doi:10.7270/q25q50wz

BindingDB Entry 50047469: Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome.

BindingDB (2017) · UC San Diego · doi:10.7270/q2222wpd

Other Proteasome Inhibitors

Garcı́a-Echeverrı́a, C. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-794-9_5

The 26S Proteasome as a Therapeutic Target in Cancer: Beyond Protease Inhibitors?

Verma, R. (2009) · Springer eBooks · doi:10.1007/978-0-387-69147-3_2

THE SECOND GENERATION PROTEASOME INHIBITOR CARFILZOMIB INTERACTS SYNERGISTICALLY WITH HDAC INHIBITORS IN DIFFUSE LARGE B-CELL LYMPHOMA CELLS THROUGH MULTIPLE MECHANISMS AND CIRCUMVENTS BORTEZOMIB RESISTANCE

Lembersky, D. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/wskn-jt96

New Therapeutic Approaches to Myeloma

Landowski, T. H., Dalton, W. S., & Salmon, S. E. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-817-5_16

Proteasome inhibitors as complementary or alternative antiviral therapeutics

Prösch, S., & Kaspari, M. (2006) · Springer eBooks · doi:10.1007/978-0-387-31047-3_17

ChemInform Abstract: Potent and Selective Inhibitors of the Proteasome: Dipeptidyl Boronic Acids.

Adams, J., Behnke, M. L., CHEN, S., Cruickshank, A., Dick, L. R., Grenier, L., Klunder, J. M., MA, Y. ‐., Plamondon, L., & Stein, R. L. (1998) · ChemInform · doi:10.1002/chin.199821191 · Cited by 1

α-Aminoboronic Acid Moieties in Boro Dipeptides Modulate Proteasome Subunit Selectivity and Provide Access to Compounds with Potent Anticancer and Anti-Inflammatory Activity

Benedik, N. S., Šterman, A., Smrdel, L., Pajk, S., Gobec, S., Časar, Z., Gobec, M., & Sosič, I. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02548 · Cited by 3

Synthesis, in Vitro and in Vivo Biological Evaluation, and Comprehensive Understanding of Structure−Activity Relationships of Dipeptidyl Boronic Acid Proteasome Inhibitors Constructed from β-Amino Acids

Zhu, Y., Wu, G., Zhu, X., Ma, Y., Zhao, X., Li, Y., Yuan, Y., Yang, J., Yu, S., Shao, F., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1009742 · Cited by 38

Synthesis, in Vitro and in Vivo Biological Evaluation, Docking Studies, and Structure−Activity Relationship (SAR) Discussion of Dipeptidyl Boronic Acid Proteasome Inhibitors Composed of β-Amino Acids

Zhu, Y., Zhu, X., Wu, G., Ma, Y., Li, Y., Zhao, X., Yuan, Y., Yang, J., Yu, S., Shao, F., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901407s · Cited by 39

Design, Synthesis, Biological Evaluation, and Structure−Activity Relationship (SAR) Discussion of Dipeptidyl Boronate Proteasome Inhibitors, Part I: Comprehensive Understanding of the SAR of α-Amino Acid Boronates

Zhu, Y., Zhao, X., Zhu, X., Wu, G., Li, Y., Ma, Y., Yuan, Y., Yang, J., Hu, Y., Ai, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9005093 · Cited by 75